Simple Fecal Blood Test Could Reduce Unnecessary Endoscopies
By HospiMedica International staff writers Posted on 04 Oct 2016 |
Image: A simple fecal test can reduce the need for endoscopy (Photo courtesy of University Medical Center Utrecht).
A new diagnostic strategy for patients with suspected serious colorectal disease (SCD) could reduce the need for endoscopy by nearly a third, according to a new study.
Researchers at University Medical Center Utrecht (UMCU; The Netherlands), Gelderse Vallei Hospital (Ede, The Netherlands) and other hospitals across the Netherlands conducted a cross-sectional diagnostic study of 810 patients with suspected SCD referred by 266 primary general practitioner (GP) practices for endoscopy; all of the patients underwent a fecal immunochemical test (FIT), which uses an antibody that recognizes human hemoglobin, and so can be used to detect the presence of blood in a patients stool sample.
The results showed that out of the 810 patients referred for an endoscopy, 669 had no SCD. Once the results of the FIT test were taken into account, the researchers found that approximately 30% of these patients could have been prevented from having an endoscopy at all, as they may have been correctly diagnosed as not having SCD during their clinical visit. The researchers also examined the benefit of adding a fecal calprotectin (FCal) test to the diagnostic strategy; while this test did improve the diagnosis of SCD, it was not to the same extent as FIT. The study was published on September 26, 2016, in BMC Medicine.
“The amount of patients that are unnecessarily referred for an endoscopy strains health care budgets and exposes patients to a small but realistic risk from endoscopy associated complications,” said lead author Sjoerd Elias, MD, of UMCU, and colleagues. “Our study found that using a test called FIT, which detects the presence of hemoglobin in the patient's feces, alongside the usual diagnostic work up done by GPs could rule out nearly a third of patients from requiring an endoscopy to check for SCD.”
SCD, which includes colorectal cancer, is difficult to diagnose as the signs and symptoms are not always clear. Any suspicion of SCD requires a GP referral to a hospital for an endoscopy, but numerous studies have shown that between 60-80% of referred patients end up not having SCD.
Related Links:
University Medical Center Utrecht
Gelderse Vallei Hospital
Researchers at University Medical Center Utrecht (UMCU; The Netherlands), Gelderse Vallei Hospital (Ede, The Netherlands) and other hospitals across the Netherlands conducted a cross-sectional diagnostic study of 810 patients with suspected SCD referred by 266 primary general practitioner (GP) practices for endoscopy; all of the patients underwent a fecal immunochemical test (FIT), which uses an antibody that recognizes human hemoglobin, and so can be used to detect the presence of blood in a patients stool sample.
The results showed that out of the 810 patients referred for an endoscopy, 669 had no SCD. Once the results of the FIT test were taken into account, the researchers found that approximately 30% of these patients could have been prevented from having an endoscopy at all, as they may have been correctly diagnosed as not having SCD during their clinical visit. The researchers also examined the benefit of adding a fecal calprotectin (FCal) test to the diagnostic strategy; while this test did improve the diagnosis of SCD, it was not to the same extent as FIT. The study was published on September 26, 2016, in BMC Medicine.
“The amount of patients that are unnecessarily referred for an endoscopy strains health care budgets and exposes patients to a small but realistic risk from endoscopy associated complications,” said lead author Sjoerd Elias, MD, of UMCU, and colleagues. “Our study found that using a test called FIT, which detects the presence of hemoglobin in the patient's feces, alongside the usual diagnostic work up done by GPs could rule out nearly a third of patients from requiring an endoscopy to check for SCD.”
SCD, which includes colorectal cancer, is difficult to diagnose as the signs and symptoms are not always clear. Any suspicion of SCD requires a GP referral to a hospital for an endoscopy, but numerous studies have shown that between 60-80% of referred patients end up not having SCD.
Related Links:
University Medical Center Utrecht
Gelderse Vallei Hospital
Latest Surgical Techniques News
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
- Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots
- Hydrogel-Based Miniaturized Electric Generators to Power Biomedical Devices
- Custom 3D-Printed Orthopedic Implants Transform Joint Replacement Surgery
- Wearable Technology Monitors and Analyzes Surgeons' Posture during Long Surgical Procedures